Assessment of the Regional Hub Model for Colorectal Cancer Services During COVID-19
Overview
The Royal Marsden Partners Cancer Hub was established as a regional collaborative network to centralize colorectal and anal cancer surgeries during the COVID-19 pandemic. This model enabled continuation of elective cancer surgeries at designated COVID-19 free sites, ensuring patient safety and resource optimization amid the healthcare crisis.
Background
The COVID-19 pandemic led to widespread disruption of healthcare services, including suspension of elective surgeries and reduced access to diagnostics and outpatient care. Intensive care units were overwhelmed, and staff shortages further complicated cancer treatment delivery. To address these challenges, the NHS implemented strategies to rationalize resources and maintain essential cancer services. The Royal Marsden Partners Cancer Hub was created to centralize colorectal cancer surgeries across London, minimizing COVID-19 exposure and ensuring timely care.
Data Highlights
The Cancer Hub involved multiple NHS trusts across London, with surgeries centralized at two COVID-19 free hospitals: Royal Marsden Hospital and BUPA Cromwell Hospital. Patients were prioritized according to NHS England guidelines, with urgent cases discussed weekly at a Clinical Prioritisation Group. Referral and preoperative protocols included self-isolation and COVID-19 screening to maintain safety. This collaborative approach allowed continued surgical treatment despite pandemic-related constraints.
Key Findings
The Cancer Hub centralized colorectal and anal cancer surgeries across multiple London NHS trusts during the pandemic.
Two designated COVID-19 free hospitals facilitated safe elective cancer surgeries, separate from acute COVID-19 care.
Patients were prioritized based on urgency following NHS England guidelines, ensuring timely treatment of life-threatening cases.
Weekly multidisciplinary and prioritization meetings enabled coordinated decision-making across trusts.
Preoperative protocols including self-isolation and COVID-19 testing minimized infection risk for patients undergoing surgery.
Clinical Implications
The regional hub model demonstrates a feasible approach to maintaining essential cancer surgeries during healthcare crises by centralizing resources and segregating COVID-19 care. Implementing strict patient prioritization and infection control protocols can optimize surgical outcomes and patient safety. This model may serve as a framework for managing cancer services during future pandemics or system-wide disruptions.
Conclusion
The Royal Marsden Partners Cancer Hub successfully ensured continuity of colorectal cancer surgery during the first COVID-19 wave by centralizing care at COVID-19 free sites and employing strategic prioritization. This collaborative network offers a viable model for sustaining cancer services amid pandemic challenges.
References
WHO/2020 -- Declaration of COVID-19 Pandemic
NHS England/2020 -- Suspension of Elective Surgery
NHS England/2020 -- Cancer Patient Management Guidelines During COVID-19
